Price Alert

Arvinas Inc. (ARVN)

NASDAQ: ARVN · Real-Time Price · USD

7.61

-0.29 (-3.67%)

At close: Sep 04, 2025, 3:59 PM

7.65

0.53%

After-hours: Sep 04, 2025, 05:19 PM EDT

-3.67% (1D)

Bid	7.59
Market Cap	558.71M
Revenue (ttm)	372.8M
Net Income (ttm)	-72.6M
EPS (ttm)	-1.01
PE Ratio (ttm)	-7.53
Forward PE	-2.71
Analyst	Buy

Ask	7.85
Volume	1,183,934
Avg. Volume (20D)	1,890,091
Open	7.87
Previous Close	7.90
Day's Range	7.47 - 7.87
52-Week Range	5.90 - 29.61
Beta	2.23

About ARVN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ARVN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ARVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Arvinas Inc. is scheduled to release its earnings on Oct 29, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 weeks ago

-15.51%

Arvinas shares are trading lower after the company... Unlock content with Pro Subscription

3 months ago

+8.82%

Arvinas shares are trading higher after the company announced its submission of an NDA to the FDA for Vepdegestrant

News

1 month ago · seekingalpha.com

Arvinas, Inc. (ARVN) Q2 2025 Earnings Call Transcript

Arvinas, Inc. (NASDAQ:ARVN ) Q2 2025 Earnings Call August 6, 2025 8:00 AM ET Company Participants Andrew R. Saik - CFO & Treasurer Angela M.

4 weeks ago · zacks.com

Arvinas, Inc. (ARVN) Reports Q2 Loss, Misses Revenue Estimates

Arvinas, Inc. (ARVN) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $0.87. This compares to a loss of $0.49 per share a year ago.

2 months ago · zacks.com

Wall Street Analysts Believe Arvinas (ARVN) Could Rally 89.85%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 89.9% in Arvinas (ARVN). While the effectiveness of this highly sought-after metric is questionable, the positi...

3 months ago · accessnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVN

NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. ("Arvinas" or the "Company") (NASDAQ:ARVN). Such investors are advise...